Business Wire

UNIVERSAL-PEACE-FED

5.8.2020 12:44:12 CEST | Business Wire | Press release

Share
Universal Peace Federation: Online Rally Calling for Peace, Reconciliation and Mutual Prosperity


(Sunday August 9th, 3 am CET)

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200805005488/en/

More than 1 Million are expected to join! World Leaders to point the way forward beyond global challenges including Covid-19, race relations, environmental problems and global economic turndown. Speakers include former UN Secretary-General Ban Ki-moon and H.E. Macky Sall, President of Senegal. UPF Co-Founder Dr. Hak Ja Han will offer a special keynote message of hope to humanity.

Registration link for online participants:

https://www.rally2020.org

World Leaders to Address “Rally of Hope”

Despite material advances and the amassing of unprecedented wealth, serious global problems remain unsolved. This is all the more striking when it is seen alongside worldwide efforts to maintain peace, resolve conflicts and end poverty by major international peace-keeping bodies, public and private.

Territorial disputes, religious and racial discord, the collapse of family values, and an aggregate of environmental issues are flaring up on all continents. Added to this is the COVID-19 pandemic which has caused catastrophic economic debt. It seems like a perfect storm.

Just such dilemmas drew the late Rev. Dr. Sun Myung Moon and his wife Dr. Hak Ja Han Moon to speak out for the realization of an ideal world. Their vision: one human family bound together by the love of God. For decades, they have advocated the philosophy of interdependence, mutual prosperity, and universal values which challenges us with the novel concept of seeing our own purpose in life fulfilled in the well-being of others.

To emphasize these values and help address related problems, the Universal Peace Federation (an NGO in general consultative status with the Economic and Social Council of the United Nations), will be hosting the latest in a series of on-line virtual summits. The Rally of Hope will be held August 9, 2020 beginning at 9:40 AM (Korean time). The official theme is, “One Million Rally of Hope for the Realization of a Heavenly Unified World of Interdependence, Mutual Prosperity, and Universal Values.”

“The goal of these assemblies is to set a cornerstone for the realization of a world of proactive international and interreligious collaboration for the good of all people,” said Dr. Thomas G. Walsh, Chairman of the Universal Peace Federation.

Ban Ki-moon, former UN Secretary-General, will give the welcome address. Congratulatory messages presented by international dignitaries will follow. Interspersed with first-class entertainment, keynote addresses will be given by H.E. Hun Sen, Prime Minister of Cambodia; H.E. Macky Sall, President of Senegal; the Hon. Brigi Rafini, Prime Minister of Niger and other world leaders.

Finally, Dr. Hak Ja Han Moon, co-founder of the Universal Peace Federation and host of the Rally, will give her keynote address.

Link:

ClickThru

Social Media:

https://www.facebook.com/EumePeace

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press release

Potential first-in-class GPC3 x 4-1BB bispecific achieves a 36% confirmed response rate at Phase 3 dose and favorable safety profile in heavily pretreated liver cancerBrain-penetrant PRMT5 inhibitor shows promising antitumor and CNS activity in the largest publicly shared MTAP-deficient datasetFirst clinical data of CEA-targeting ADC demonstrates encouraging and sustained responses in CEAhigh NSCLC BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to dise

Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press release

- Vertex is on track for the U.S. FDA Prescription Drug User Fee Act (PDUFA) date of November 30 for potential accelerated approval of povetacicept –- Data published in NEJM and presented at ASN highlight povetacicept’s unique trifecta of efficacy, favorable safety, and the simplicity of dosing at-home every 4 weeks with a low-volume autoinjector –- Data presented at ASN include a qualitative study examining patient perspectives on current and emerging IgAN therapies, showing that 96% of participants preferred an autoinjector over a prefilled syringe, and 80% of participants preferred dosing every 4 weeks versus weekly dosing - - New clinical studies of povetacicept underway including a study evaluating patient experience on povetacicept administered via autoinjector - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Soc

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press release

New data from HERIZON-GEA-01 Phase 3 trial show 36-month overall survival of nearly 40% with TEVIMBRA plus ZIIHERA and chemotherapy, and median OS reaching 27 monthsTEVIMBRA-containing arm was associated with a four-month longer median OS compared with ZIIHERA plus chemotherapy BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne,

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:10:00 CEST | Press release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press release

Collaboration will establish the roadmap for bringing Pony.ai robotaxis to Kazakhstan on the inDrive ride-hailing platform, leveraging the NVIDIA Hyperion and the NVIDIA Halos safety system. inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a lea

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye